FSU COM Grand Rounds
Taking Translation into the Clinic: Can We Improve the Probability of Success?
At the conclusion, the participant should be able to:
1) SUMMARIZE the drug development process and challenges facing the industry; 2) DESCRIBE the use of biomarkers in drug development; 3) DESCRIBE the application of biomarkers in clinical trials studying type 2 diabetes mellitus.
Questions and answers will allow for audience participation.